According to filings with the U.S. Securities and Exchange Commission, DarioHealth is raising up to $22,422,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Erez Raphael played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About DarioHealth
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Move, which helps to prevent and treat the most common MSK conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; Dario One, a full suite of chronic condition management solutions; DarioEngage platform; and Dario blood glucose monitoring system. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and Dario smart diabetes management solutions, including live clinical coaching, content, automated journeys, hardware, and lifestyle coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

To learn more about DarioHealth, visit http://shop.mydario.com/

Contact:
Erez Raphael, Chief Executive Officer
646-665-4667
https://www.linkedin.com/in/erezraphael/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.